✦ LIBER ✦

Placebo-controlled study of MDL 11,939 in patients with generalized anxiety disorder

✍ Scribed by N.R. Cutler; J.J. Sramek; R.E. Robinson; A. Suri

Book ID: 118857042
Publisher: Elsevier Science
Year: 1994
Tongue: English
Weight: 323 KB
Volume: 35
Category: Article
ISSN: 0006-3223
DOI: 10.1016/0006-3223(94)90894-x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Adverse events in placebo-treated patien

Adverse events in placebo-treated patients with generalized anxiety disorder

✍ John J. Sramek; Edyta J. Frackiewicz; Marlena A. Piercy; Neil M. Kurtz; Michael 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 43 KB 👁 2 views

Olanzapine Augmentation of Fluoxetine fo

Olanzapine Augmentation of Fluoxetine for Refractory Generalized Anxiety Disorder: A Placebo Controlled Study

✍ Mark H. Pollack; Naomi M. Simon; Alyson K. Zalta; John J. Worthington; Elizabeth 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 102 KB

Double-blind, placebo-controlled study o

Double-blind, placebo-controlled study of once daily venlafaxine XR In outpatients with generalized anxiety disorder

✍ J.T. Haskins; L. Aguiar; A. Pallay; R. Rudolph 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 179 KB

P.4.a.016 Agomelatine in generalized anx

P.4.a.016 Agomelatine in generalized anxiety disorder: a randomized, placebo-controlled, study

✍ D.J. Stein; A. Ahokas; A. Fabiano 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 68 KB

Placebo-controlled evidence for the use

Placebo-controlled evidence for the use of antidepressants in Generalized Anxiety Disorder

✍ E. Salinas 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 171 KB

Escitalopram in the treatment of general

Escitalopram in the treatment of generalized anxiety disorder: Double-blind, placebo controlled, flexible-dose study

✍ Jonathan R.T. Davidson; Anjana Bose; Andrew Korotzer; Hongjie Zheng 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB 👁 2 views

Escitalopram has been shown in clinical trials to improve anxiety symptoms associated with depression, panic disorder, and social anxiety disorder. This study was designed to evaluate the efficacy and tolerability of escitalopram in the treatment of generalized anxiety disorder (GAD). Outpatients (1